Want to see VCYT full AI Analyst Report?
Total Valuation
Veracyte has a market cap or net worth of $4.63B. The enterprise value is $3.87B.
Market Cap$4.63B
Enterprise Value$3.87B
Share Statistics
Veracyte has 79,792,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,792,650
Owned by Insiders1.81%
Owned by Institutions24.09%
Financial Efficiency
Veracyte’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.34%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.34%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee684.96K
Profits Per Employee87.88K
Employee Count755
Asset Turnover0.37
Inventory Turnover7.65
Valuation Ratios
The current PE Ratio of Veracyte is 50.7. Veracyte’s PEG ratio is 0.31.
PE Ratio50.7
PS Ratio6.40
PB Ratio2.53
Price to Fair Value2.53
Price to FCF26.13
Price to Operating Cash Flow26.88
PEG Ratio0.31
Income Statement
In the last 12 months, Veracyte had revenue of 517.14M and earned 66.35M in profits. Earnings per share was 0.84.
Revenue517.14M
Gross Profit360.05M
Operating Income74.15M
Pretax Income68.20M
Net Income66.35M
EBITDA89.62M
Earnings Per Share (EPS)0.84
Cash Flow
In the last 12 months, operating cash flow was 166.16M and capital expenditures -11.35M, giving a free cash flow of 154.81M billion.
Operating Cash Flow166.16M
Free Cash Flow154.81M
Free Cash Flow per Share1.94
Dividends & Yields
Veracyte pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change107.39%
50-Day Moving Average46.11
200-Day Moving Average39.86
Relative Strength Index (RSI)59.79
Average Volume (3m)1.38M
Important Dates
Veracyte upcoming earnings date is Aug 11, 2026, After Close (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Veracyte as a current ratio of 8.15, with Debt / Equity ratio of 2.93%
Current Ratio8.15
Quick Ratio7.81
Debt to Market Cap0.00
Net Debt to EBITDA-3.60
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Veracyte has paid 1.85M in taxes.
Income Tax1.85M
Effective Tax Rate0.03
Enterprise Valuation
Veracyte EV to EBITDA ratio is 33.31, with an EV/FCF ratio of 23.58.
EV to Sales5.77
EV to EBITDA33.31
EV to Free Cash Flow23.58
EV to Operating Cash Flow21.90
Balance Sheet
Veracyte has $439.06M in cash and marketable securities with $39.33M in debt, giving a net cash position of $399.73M billion.
Cash & Marketable Securities$439.06M
Total Debt$39.33M
Net Cash$399.73M
Net Cash Per Share$5.01
Tangible Book Value Per Share$5.77
Margins
Gross margin is 71.31%, with operating margin of 14.34%, and net profit margin of 12.83%.
Gross Margin71.31%
Operating Margin14.34%
Pretax Margin13.19%
Net Profit Margin12.83%
EBITDA Margin17.33%
EBIT Margin13.19%
Analyst Forecast
The average price target for Veracyte is $50.43, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$50.43
Price Target Upside49.20% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast16.91%
EPS Growth Forecast159.69%